Investor directoryAdBio partners
AdBio partners uniquely combines early-stage investment with strong entrepreneurial support to catalyze the growth of life sciences startups.
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- Paris, France
- Founded
- 2015
Portfolio companies
More portfolio companies
Agomab Therapeutics (NAS: AGMB)UnivercellsEvlaBioCephagenixTenpoint TherapeuticsDiogenXSparingVisionNeGio TherapeuticsDepth Charge TherapeuticsAnoat TherapeuticsArthex BiotechYukin TherapeuticsRibonexusCalida TherapeuticsAlderaan BiotechnologyThabor TherapeuticsAndzonbio1Urania TherapeuticsGamut Therapeutics
Recent rounds
Augustine Therapeutics NV
€77.7MSeries AHealthTechNovo HoldingsleadJeitoleadAdBio partnersAsabys PartnersPMVVIB · +4 more in the source
Belgiumsiliconcanals.com
Rounds AdBio partners took part in, as reported by the linked articles. See who else is investing right now.
Questions founders ask
- How much does AdBio partners typically invest?
- AdBio partners states a typical cheque of €1M – €30M.
- Which stages does AdBio partners invest in?
- AdBio partners invests at Seed and Series A.
- Where is AdBio partners based?
- AdBio partners is headquartered in Paris, France.
Does AdBio partners fit your round?
In 30 minutes you'll know which funds matter for your round.
Request accessAre you AdBio partners? Tell us what to correct and we will update it — or ask us to remove the entry.